The results of a study presented today at the European League Against Rheumatism Annual Congress revealed that DNA methylation, a mechanism that regulates gene expression, could influence the progression of structural damage to the joints and spine in ankylosing spondylitis (AS). The data findings showed significant associations between a low methylation score and more radiographic progression (X-ray) of the disease, and implicated smoking in worsening of disease outcome.
AS is a painful and progressive form of arthritis caused by chronic inflammation of the joints in the spine, state the team. Prevalence of AS varies globally, and is estimated at 23.8 per 10,000 in Europe and 31.9 per 10,000 in North America. Damage caused by AS impairs spinal mobility, which reduces a patients’ ability to perform daily activities and negatively impacts their quality of life. Radiography is the classical tool for identifying these structural changes.
Previous studies show that DNA methylation is one of several epigenetic mechanisms; epigenetics is the study of factors aside from the DNA sequence that control whether genes are read or not and thus influence expression and function of genes. Although epigenetic mechanisms are essential for controlling normal development, abnormal epigenetic change may be seen when they are implicated in disease.
The current study consisted of 75 AS patients that had radiographs on average every three years, with 35 of these patients exhibiting radiographic progression. The team investigated epigenetic variants recently linked to ankylosis, and uncovered a significant association between smoking, methylation status and radiographic progression.
The results show a significant association between smoking, methylation status and radiographic progression; a low total methylation score was significantly associated with more radiographic progression, and worse radiographic progression was observed in smokers than non-smokers (not statistically significant). The researchers hypothesise that environmental triggers, such as smoking, could lead to epigenetic changes that accelerate the damage caused by the disease, and that investigating the mechanisms that control these changes could one day lead to novel therapeutic targets for AS.
The team state that this is the first study to demonstrate how epigenetic factors can influence radiographic progression in AS and believe that this environmental factor should be taken into consideration when treating AS patients.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.